U.S. health officials have fast-tracked the coronavirus vaccine. The National Institutes of Health is working with Moderna on the vaccine. The agency hopes to begin clinical trials in three months. (CNBC)

The Food and Drug Administration has finalized its gene therapy guidelines in anticipation of more new treatments. The FDA has issued guidance on how it will evaluate gene therapy drugs as orphan drugs and guidelines for pharma companies on manufacturing, testing and long-term follow up on the products. (BioPharma Dive)

Pfizer has reported a revenue decline in Q4. The company attributed the year-over-year drop to the divestment of its consumer business last summer. Pfizer’s pharmaceuticals division rose 8% in 2019. (MM&M)

There have been no new deaths from the vaping illness since Jan. 16. This is the first time in recent weeks that the Centers for Disease Control and Prevention has found no new deaths from the vaping-related lung illness. Total confirmed cases reached 2,711. (Reuters

Allergan will sell two products to move forward with its acquisition of AbbVie. The company is selling an experimental Crohn’s disease and ulcerative colitis treatment to AstraZeneca and pancreatic treatment Zenpep to Nestlé. (MarketWatch)